-(2)-1.jpg "Top Drug Delivery Solutions Companies in APAC")
The medical field is undergoing a rapid evolution as advancements in science and technology continue to reshape the landscape. Conventional drug delivery methods are being replaced by more efficient systems that can enhance therapeutic efficacy, reduce toxicity, increase patient compliance, and enable entirely new medical treatments. The recent technological developments in drug delivery systems, including wearable drug delivery systems, implantable devices, nano drug delivery systems, and 3D-printed drug delivery systems, are driving significant improvements in patient outcomes, medication compliance, and healthcare access.
In that regard, wearable and implantable drug delivery systems have become increasingly popular due to their convenience and long-term medication use. The devices can be programmed to deliver specific dosages of medication at precise times. This makes it an ideal option for patients who require ongoing medication and have difficulty adhering to a strict medication schedule.
Nano drug delivery systems have also emerged as an innovative trend in drug delivery. These systems use nanoparticles to deliver medication to specific cells or tissues in the body, reducing side effects and improving medication efficacy. This targeted approach can also help reduce the required dosage of medication, making it a safer and more cost-effective option for patients.
Driven by these trends, the global pharmaceutical drug delivery market is projected to reach $2206.5 billion by 2026, exhibiting a CAGR of 5.9 percent.
To put the spotlight on many other key developments in the industry, MedTech Outlook APAC illustrates how companies are leveraging the latest developments in drug deliver to enhance organizational performance. The edition also features thought leadership articles from Ts. Dr. James Chong, Director, ALLIED HEALTH, Thomson Hospital Kota Damansara; Alessandro Roncacci, Senior VP and Chief Medical Officer at Affidea; and Dr. Christopher Leo, Specialist in Renal Medicine and Consultant, Raffles Internal Medicine Center.
In this edition of MedTech Outlook, we also bring to you the story of the top drug delivery companies in the APAC region that deliver the best outcomes for their clients. Standing out in the list is IMGT, a clinical-stage biotechnology company based in South Korea that offers innovative oncology delivery solutions. It provides IMD10, an anti-tumor medication, which is a cost-effective alternative to cancer treatments.
Through the following pages, we aim to shine a light on the latest developments implemented by companies in the drug delivery systems space. We would like to know your thoughts.
